Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report
Rationale:
Hypophosphatasia is an inborn error of metabolism that can appear any time in life, mainly with bone manifestations due to low alkaline phosphatase activity. Asfotase alfa is a specific enzyme reposition treatment that has shown promising results in children; however, there are few reports about the outcomes in adult patients.
Patient concerns:
A 36-year-old male presented with an early history of craniosynostosis, short stature, and multiple fractures since the age of 13 years—which needed numerous surgical corrections. He was admitted with a previous diagnosis of osteogenesis imperfecta, taking alendronate, calcium carbonate, cholecalciferol, and calcitriol. Bone mineral density was low (lumbar spine Z-score = −3.0 SD), with impairment of all parameters of high-resolution peripheral quantitative computed tomography (HR-pQCT). Kidney impairment was also observed with reduced creatinine clearance, nephrolithiasis, and nephrocalcinosis.
Diagnosis:
Alkaline phosphatase was unexpectedly low (6 U/L, reference value: 30–120 U/L), with high serum vitamin B6 (260 mcg/L, reference value: 5.2–34.1). Genetic testing showed a homozygous missense mutation in ALPL gene c.443 C>T: p.Thr148Ile.
Intervention:
Asfotase alfa was requested due to important bone deterioration, ambulatory disability, and kidney impairment. It was given subcutaneously 2 mg/kg per dose, 3 times a week, for 12 months before reassessment.
Outcomes:
Bone mineral densities of ...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Calcium | Children | Craniofacial Surgery | CT Scan | Disability | Genetics | Internal Medicine | Kidney Stones | Lessons | Orthopaedics | Osteogenesis Imperfecta (brittle bone disease) | Urology & Nephrology | Vitamin B6 | Vitamin D | Vitamin D3 | Vitamins